References
Original article
Castellino, S. M. et al. Brentuximab vedotin with chemotherapy in pediatric high-risk Hodgkin’s lymphoma. N. Engl. J. Med. 387, 1649–1660 (2022)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sidaway, P. Brentuximab vedotin improves outcomes. Nat Rev Clin Oncol 20, 2 (2023). https://doi.org/10.1038/s41571-022-00715-0
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41571-022-00715-0
- Springer Nature Limited